BDPM

Bone Density in Pediatric Mastocytosis: Who is at risk of osteoporosis? - Bone density in Pediatric Mastocytosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON58050

Enrollment

Registered

2025-10-13

Start date

2025-10-20

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mastocytosis Mastocytosis

Interventions

Standard care according to protocol, based on Dutch national mastocytosis guidelines.

Eligibility

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: Patients aged 4-18 years old, patient is followed at the Erasmus MC Sophia Kinderziekenhuis for mastocytosis.

Exclusion criteria

Exclusion criteria: Incomplete dataOther medical conditions that may affect bone mineral density

Design outcomes

Primary

Measure	Time frame
To assess bone mineral density in these patients.	—

Secondary

Measure	Time frame
To assess differences in bone mineral density between different types of mastocytosis and to potentially define disease-related risk factors for osteoporosis.	—

Countries

Netherlands

Contacts

Public ContactSGMA Pasmans

Erasmus MC, Universitair Medisch Centrum Rotterdam

s.pasmans@erasmusmc.nl(010) 703 73 80

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)